SI-BONE ($SIBN) is expected to release its quarterly earnings data on Monday, January 12th after market close, per Finnhub. Analysts are expecting revenue of $66,243,696 and earnings of -$0.11 per share.
You can see Quiver Quantitative's $SIBN stock page to track data on insider trading, hedge fund activity, congressional trading, and more.
SI-BONE Insider Trading Activity
SI-BONE insiders have traded $SIBN stock on the open market 50 times in the past 6 months. Of those trades, 0 have been purchases and 50 have been sales.
Here’s a breakdown of recent trading of $SIBN stock by insiders over the last 6 months:
- JEFFREY W DUNN has made 0 purchases and 6 sales selling 100,586 shares for an estimated $1,912,022.
- ANSHUL MAHESHWARI (Chief Financial Officer) has made 0 purchases and 13 sales selling 37,904 shares for an estimated $711,142.
- MICHAEL A. PISETSKY (SVP, Ops & Adm/Chief Legal Ofr) has made 0 purchases and 12 sales selling 33,245 shares for an estimated $625,395.
- LAURA FRANCIS (Chief Executive Officer) has made 0 purchases and 10 sales selling 33,506 shares for an estimated $562,631.
- ANTHONY J RECUPERO (President, Commercial Ops) has made 0 purchases and 8 sales selling 14,654 shares for an estimated $246,048.
- JOHN GORDON FREUND sold 12,132 shares for an estimated $193,997
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
SI-BONE Revenue
SI-BONE had revenues of $48.7M in Q3 2025. This is an increase of 20.61% from the same period in the prior year.
You can track SIBN financials on Quiver Quantitative's SIBN stock page.
SI-BONE Hedge Fund Activity
We have seen 88 institutional investors add shares of SI-BONE stock to their portfolio, and 82 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- CADIAN CAPITAL MANAGEMENT, LP added 595,000 shares (+inf%) to their portfolio in Q3 2025, for an estimated $8,758,400
- HOLOCENE ADVISORS, LP removed 585,311 shares (-100.0%) from their portfolio in Q3 2025, for an estimated $8,615,777
- POINT72 (DIFC) LTD added 581,695 shares (+19887.0%) to their portfolio in Q3 2025, for an estimated $8,562,550
- AMERICAN CENTURY COMPANIES INC added 521,683 shares (+22.5%) to their portfolio in Q3 2025, for an estimated $7,679,173
- HARBOR CAPITAL ADVISORS, INC. removed 423,688 shares (-73.9%) from their portfolio in Q3 2025, for an estimated $6,236,687
- WELLINGTON MANAGEMENT GROUP LLP added 364,897 shares (+74.7%) to their portfolio in Q3 2025, for an estimated $5,371,283
- IMPAX ASSET MANAGEMENT GROUP PLC added 333,249 shares (+48.2%) to their portfolio in Q3 2025, for an estimated $4,905,425
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
SI-BONE Government Contracts
We have seen $38,550 of award payments to $SIBN over the last year.
Here are some of the awards which we have have seen pay out the most over the last year:
- PROSTHETIC IMPLANT: $23,100
- HARDWARE: $15,450
To track government contracts to publicy traded companies, check out Quiver Quantitative's government contracts dashboard.
SI-BONE Analyst Ratings
Wall Street analysts have issued reports on $SIBN in the last several months. We have seen 3 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- Truist Securities issued a "Buy" rating on 12/18/2025
- Needham issued a "Buy" rating on 12/16/2025
- Cantor Fitzgerald issued a "Overweight" rating on 08/05/2025
To track analyst ratings and price targets for SI-BONE, check out Quiver Quantitative's $SIBN forecast page.
SI-BONE Price Targets
Multiple analysts have issued price targets for $SIBN recently. We have seen 5 analysts offer price targets for $SIBN in the last 6 months, with a median target of $25.0.
Here are some recent targets:
- David Rescott from Truist Securities set a target price of $23.0 on 12/18/2025
- Caitlin Roberts from Canaccord Genuity set a target price of $27.0 on 12/17/2025
- David Saxon from Needham set a target price of $27.0 on 12/16/2025
- Drew Ranieri from Morgan Stanley set a target price of $23.0 on 12/02/2025
- Ross Osborn from Cantor Fitzgerald set a target price of $25.0 on 08/05/2025
This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.
